NCT00069160
- Conditions
- Adnexal Diseases, Cervix Neoplasms, Endocrine Gland Neoplasms, +28 more
- Locations
-
- National Institutes of Health Bethesda, Maryland, United States
Clinical trial condition
Ovarian Neoplasms
Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.
194 public trials
42 recruiting studies
Ovarian Neoplasms trial results
NCT00452985
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
- Locations
-
- Sanofi-Aventis Dhaka, Bangladesh
NCT00102973
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
- Locations
-
- Little Rock Hematology Oncology Little Rock, Arkansas, United States
- Arkansas Oncology Associates Little Rock, Arkansas, United States
- Little Rock Hematology Oncology Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
NCT00130520
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
NCT00231855
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
- Locations
-
- Montefiore Medical Center The Bronx, New York, United States
Completed
EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer
NCT00035100
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +22 more
- Locations
-
- Novartis Investigative Site New Brunswick, New Jersey, United States
- Novartis Investigative Site Toronto, Ontario, Canada
- Novartis Investigative Site Enschede, Netherlands
- Novartis Investigative Site Amsterdam, Netherlands
NCT00436657
- Conditions
- Abdominal Neoplasms, Adenocarcinoma, Adnexal Diseases, +52 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00288821
- Conditions
- Adnexal Diseases, Cervix Neoplasms, Endocrine Gland Neoplasms, +25 more
- Locations
-
- University Medical Centre Utrecht Utrecht, Pb 85500, Netherlands
Completed
Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients
NCT01523652
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- ASO Ordine Mauriziano Turin, Italy
NCT00243685
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +25 more
- Locations
-
- Nashville Breast Center Nashville, Tennessee, United States
- Nashville Oncology Associates Nashville, Tennessee, United States
- Cancer Care Centers of South Texas San Antonio, Texas, United States